The current role and perceived benefits and barriers of secondary care pharmacists facilitating patient participation in Clinical Trials of Investigational Medicinal Products (CTIMPs) conducted within the NHS: A cross-sectional survey.
health services research
Journal
Journal of evaluation in clinical practice
ISSN: 1365-2753
Titre abrégé: J Eval Clin Pract
Pays: England
ID NLM: 9609066
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
28
02
2018
revised:
27
09
2018
accepted:
04
01
2019
pubmed:
29
1
2019
medline:
29
7
2021
entrez:
29
1
2019
Statut:
ppublish
Résumé
Secondary care pharmacists are well positioned within the healthcare system to communicate with patients and provide guidance and advice regarding drug treatments. They are able to broaden the opportunities to raise the profile of Clinical Trials of Investigational Medicinal Products (CTIMPs) and positively influence research. This research aimed to investigate the perceived benefits and barriers of secondary care pharmacists being involved in CTIMPs, their current role, and the perceived benefits and barriers of developing their role in facilitating patient participation for CTIMPs (eg, by identifying or recruiting potential participants). A cross-sectional quantitative online survey circulated to pharmacy professionals within the UK. Involvement in CTIMPs and the facilitation of patient participation offered several benefits including improved communication and relationships with other healthcare professionals, developing the profession, developing training and knowledge, and exploring a personal interest. The main barriers to involvement included a lack of opportunities or awareness of opportunities, time, and funding or resources. Those employed at sites with a larger number of CTIMPs agreed more with the disadvantages; however, they also showed greater agreeance towards the benefits of pharmacy being involved in facilitating patient participation. Most respondents do not currently have a role in identifying or recruiting potential participants. Despite this, being involved in CTIMPs and the facilitation of patient participation was suggested to offer several benefits. Given many participants agreed there are barriers to their involvement, future research should focus on exploring organizational and individual challenges with the aim of enabling pharmacists to support recruitment activities.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
142-148Subventions
Organisme : Health Education Yorkshire & Humber
Informations de copyright
© 2019 John Wiley & Sons, Ltd.
Références
Eccles M, Grimshaw J, Walker A, Johnston M, Pitts N. Changing the behavior of healthcare professionals: the use of theory in promoting the uptake of research findings. J Clin Epidemiol. 2005;58(2):107-112.
Spilsbury K, Petherick E, Cullum N, Nelson A, Nixon J, Mason S. The role and potential contribution of clinical research nurses to clinical trials. J Clin Nurs. 2008;17(4):549-557.
Barber N, Blackett A, Batty R. Does a high workload decrease ward pharmacists' clinical monitoring? Int J Pharm Pract. 1993;2(3):152-155.
Légaré F, Stacey D, Turcotte S, et al. Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Libr. 2014. https://doi.org/10.1002/14651858.CD006732.pub3
Simmons D, Chapped J, Getz KA, Hallinan ZP, Schrock BP, Smith DL. Are pharmacists a Viable Channel for education about clinical trial participation? Drug Inf J. 2011;45(4):443-453.
Gul RB, Ali PA. Clinical trials: the challenge of recruitment and retention of participants. J Clin Nurs. 2010;19(1-2):227-233.
Donovan JL, Peters TJ, Noble S, et al. Who can best recruit to randomized trials?: randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study). J Clin Epidemiol. 2003;56(7):605-609.
Lowres N, Neubeck L, Salkeld G, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111(6):1167-1176.
McDonald AM, Knight RC, Campbell MK, et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006;7(1):9.
Awaisu A, Alsalimy N. Pharmacists' involvement in and attitudes toward pharmacy practice research: a systematic review of the literature. Res Social Adm Pharm. 2015;11(6):725-748.
Shaheed CA, Maher CG, Williams KA, McLachlan AJ. Participation of pharmacists in clinical trial recruitment for low back pain. Int J Clin Pharm. 2014;36(5):986-994.
Lowrie R, Morrison G, Lees R, et al. Research is “a step into the unknown”: an exploration of pharmacists' perceptions of factors impacting on research participation in the NHS. BMJ Open. 2015;5(12):e009180.
Fletcher B, Gheorghe A, Moore D, Wilson S, Damery S. Improving the recruitment activity of clinicians in randomised controlled trials: a systematic review. BMJ Open. 2012;2(1):e000496.
Norton C, Sinclair A, Marriott J. Supporting MCRN research through improving clinical trial delivery by hospital pharmacies. Arch Dis Child. 2011;96(4):e1-e1.
Krige A. The impact of the National Institute for Health Research on regional intensive care research: a case study from Cumbria and Lancashire. J Intensive Care Society. 2013;14(2):126-132.
Majumdar SR, Roe MT, Peterson ED, Chen AY, Gibler WB, Armstrong PW. Better outcomes for patients treated at hospitals that participate in clinical trials. Arch Intern Med. 2008;168(6):657-662.